| 1 | KIR2DL1, KIR2DL2, KIR2DL3, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5, KIR3DS1 |
| Alternatively spliced forms of human killer inhibitory receptors. | |
| Dohring C, et al. | |
| Immunogenetics 44 : 227-230. 1996 | |
| 2 | KIR2DL2, KIR2DL3, KIR2DL4, KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5 |
| Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. | |
| Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L. | |
| J Exp Med 182 : 875-884. 1995 | |